These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7535829)

  • 21. [Poliovirus immunology: vaccines, problems for the prevention/eradication and future interventions].
    Fernández-Cruz Pérez E; Rodríguez-Sainz C
    Rev Esp Salud Publica; 2013; 87(5):443-54. PubMed ID: 24322281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Strain-specific antibodies as an indicator of the circulation of wild poliomyelitis viruses and their role in the formation of collective immunity in the population].
    Seĭbil' VB; Malyshkina LP; Lavrova IK; Efimova VF
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (4):26-31. PubMed ID: 15481915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The final stages of the global eradication of polio.
    John TJ
    N Engl J Med; 2000 Sep; 343(11):806-7. PubMed ID: 10984572
    [No Abstract]   [Full Text] [Related]  

  • 26. [Collective poliomyelitis immunity in the adult population and its impact on eradication of this infection].
    Seĭbil' VB; Malyshkina LP; Lavrova IK; Efimova VF
    Vopr Virusol; 2007; 52(3):44-7. PubMed ID: 17601053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073.
    Kouiavskaia DV; Dragunsky EM; Liu HM; Oberste MS; Collett MS; Chumakov KM
    Antivir Ther; 2011; 16(7):999-1004. PubMed ID: 22024515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED; Rasksen CJ; Christensen J
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A competition immunoprecipitation assay of unlabeled poliovirus antigens.
    Rombaut B; Jore J; Boeyé A
    J Virol Methods; 1994 Jun; 48(1):73-9. PubMed ID: 7962262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monovalent oral poliovirus vaccines--a good tool but not a total solution.
    Ehrenfeld E; Chumakov K
    N Engl J Med; 2008 Oct; 359(16):1726-7. PubMed ID: 18923176
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV+OPV and young adults immunized with OPV.
    Lukashev AN; Yarmolskaya MS; Shumilina EY; Sychev DA; Kozlovskaya LI
    Virus Res; 2016 Feb; 213():162-164. PubMed ID: 26657881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
    Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB
    Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monovalent type 1 oral poliovirus vaccine in newborns.
    el-Sayed N; el-Gamal Y; Abbassy AA; Seoud I; Salama M; Kandeel A; Hossny E; Shawky A; Hussein HA; Pallansch MA; van der Avoort HG; Burton AH; Sreevatsava M; Malankar P; Wahdan MH; Sutter RW
    N Engl J Med; 2008 Oct; 359(16):1655-65. PubMed ID: 18923170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Coxsackievirus B4 proteins VP0 and 2C in Escherichia coli and generation of virus protein recognizing antisera.
    Härkönen T; Hovi T; Roivainen M
    J Virol Methods; 1997 Dec; 69(1-2):147-58. PubMed ID: 9504760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Humoral poliomyelitis immunity in children inoculated with a live poliomyelitis vaccine].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
    Vopr Virusol; 1984; 29(2):251-3. PubMed ID: 6328770
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays.
    Uma M; Rao PP; Nagalekshmi K; Hegde NR
    Protein Expr Purif; 2016 Dec; 128():115-22. PubMed ID: 27565898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. A comparative study in children immunized with live, inactivated, or both types of poliovirus vaccines.
    Böttiger M
    Arch Gesamte Virusforsch; 1971; 35(2):251-5. PubMed ID: 4332939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.